Accueil
Tous les communiqués
MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)

publié le 08/10/2024 à 08:00 par MEDESIS PHARMA (EPA:ALMDP)

MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)

Voir toutes les actualités de MEDESIS PHARMA